Impact of 6 Mercaptopurine (6MP) Pill-Taking Habits on Adherence, Thioguanine Nucleotide (TGN) Levels and Relapse Risk in Children with Acute Lymphoblastic Leukemia (ALL): Results from a Children’s Oncology Group (COG) Study (AALL03N1)
Lindsey Hageman(Tianjin Chengjian University), Ravi Bhatia(University of Alabama at Birmingham), Amanda Termuhlen, Mary V. Relling(St. Jude Children's Research Hospital), F. Lennie Wong(Tianjin Chengjian University), Anne Angiolillo(Children's National), William E. Evans(St. Jude Children's Research Hospital), A. Kim Ritchey(Children's Hospital of Pittsburgh), Wendy Landier(University of Alabama at Birmingham), David S. Dickens(Albert Einstein College of Medicine), Leo Mascarenhas(University of Southern California), Kelly W. Maloney(Children's Hospital Colorado), William L. Carroll(NYU Langone Health), Yanjun Chen(Tianjin Chengjian University), Heeyoung Kim(City of Hope), Nancy Kornegay(Tianjin Chengjian University), Jacqueline Casillas(University of California, Los Angeles), Glen Lew(Emory University), Bruce Bostrom(Minnesota West Community & Technical College)
Cited by 2
Related Papers
Treatment of Acute Lymphoblastic Leukemia
|New England Journal of Medicine|2006|2k
Classification, subtype discovery, and prediction of outcome in pediatric acute lymphoblastic leukemia by gene expression profiling
|Cancer Cell|2002|1.9k
Deletion of <i>IKZF1</i> and Prognosis in Acute Lymphoblastic Leukemia
|New England Journal of Medicine|2009|1.4k
Targetable Kinase-Activating Lesions in Ph-like Acute Lymphoblastic Leukemia
|New England Journal of Medicine|2014|1.4k